BusinessPetLife Pharmaceuticals Announces the Addition of Dr. Simon Wood PhD as the Company’s new Scientific Officer with plans to expand its Current Portfolio of Veterinarian Drugs and NutraceuticalsBy Nasdaq OMXOct 19, 2016, 7:15 PM UTC
BusinessActinium Announces Acceptance of Actimab-A Data for Poster Presentation at American Society of Hematology Annual MeetingBy Nasdaq OMXOct 19, 2016, 11:00 AM UTC
BusinessActinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Iomab-BBy Nasdaq OMXOct 18, 2016, 11:00 AM UTC
BusinessInspyr Therapeutics Appoints Richard Buller, M.D., Ph.D. to Board of DirectorsBy Nasdaq OMXOct 13, 2016, 11:00 AM UTC
BusinessInspyr Therapeutics Strengthens Clinical Development Capabilities with Appointment of Michael Elliott as Vice President of Clinical OperationsBy Nasdaq OMXOct 11, 2016, 11:00 AM UTC
BusinessCascadian Therapeutics Announces Presentation of Tucatinib in Combination Therapy in Patients with Cutaneous HER2+ Metastatic Breast CancerBy Nasdaq OMXOct 10, 2016, 11:10 AM UTC
BusinessActinium Announces Closing of Public Offering of Common StockBy Nasdaq OMXOct 4, 2016, 8:15 PM UTC
BusinessActinium Announces Pricing of Public Offering of Common StockBy Nasdaq OMXSep 29, 2016, 12:16 PM UTC
